Showing results (41-50 of 6,879) with videos related to
Sort By:
Pageof 688
Leukemia Research|December 27, 2014
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapyYuki Nakajima, Naoto Tomita, Megumi Itabashi, et al.Leukemia Research|December 28, 2014
Tolerability of induction chemotherapy dosing practices in acute myeloid leukemia patientsKaylene M Peric, David J ReevesLeukemia Research|December 28, 2014
The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemiaYuping Cheng, Zebin Luo, Shilong Yang, et al.Leukemia Research|July 8, 2014
Iron chelators induce autophagic cell death in multiple myeloma cellsVinod Pullarkat, Zhuo Meng, Cecile Donohue, et al.Leukemia Research|September 2, 2014
Aberrant proteomic expression of NSRP70 and its clinical implications and connection to the transcriptional level in adult acute leukemiaDan-Bee Choi, Moo-Rim Park, Hak-Ryul Kim, et al.Leukemia Research|June 9, 2012
miRNA mediated up-regulation of cochaperone p23 acts as an anti-apoptotic factor in childhood acute lymphoblastic leukemiaXiao Liu, Limin Zou, Lin Zhu, et al.Leukemia Research|March 26, 2013
MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemiaEbru Coskun, Martin Neumann, Cornelia Schlee, et al.Leukemia Research|March 26, 2013
The automated monocyte count is independently predictive of overall survival from diagnosis in chronic lymphocytic leukaemia and of survival following first-line chemotherapyRanjana Mazumdar, Paul Evans, Rachel Culpin, et al.Leukemia Research|March 26, 2013
Patterns of erythropoiesis-stimulating agent use among Medicare beneficiaries with myelodysplastic syndromes and consistency with clinical guidelinesAmy J Davidoff, Sheila R Weiss, Maria R Baer, et al.Leukemia Research|September 10, 2015
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Naoto Tomita, Masataka Taguri, et al.Pageof 688